For all you posters bawling about Canopy's loss...Medreleaf (LEAF) just released fiscal 2017 results with $40M revenue, $10M net profit, $13.85M adjusted EBITDA and $1.59 cash cost per gram, but nobody seems to care. Those numbers are comparable with Canopy and with the immedate profits that all you Canopy snifflers want.